Sulzer Gearing Up To Ship BAK/C Cervical Fusion Cage In May
This article was originally published in The Gray Sheet
Executive Summary
Sulzer Spine-Tech is building inventory in preparation to launch its BAK/C cervical interbody fusion cage in the next three weeks following FDA approval via premarket approval application, announced April 23.
You may also be interested in...
Rhakoss Spinal Implant May Be Safer Alternative To Allograft – Orthovita
Orthovita is emphasizing its Rhakoss synthetic bone spinal implant as a potentially safer alternative to allograft for cervical spinal fusion surgery
Rhakoss Spinal Implant May Be Safer Alternative To Allograft – Orthovita
Orthovita is emphasizing its Rhakoss synthetic bone spinal implant as a potentially safer alternative to allograft for cervical spinal fusion surgery
Sulzer Biologics Ne-Osteo U.S. Fusion Filing Awaits Marketing Agreement
Sulzer Biologics says it will find a U.S. distribution partner for the Ne-Osteo Spine bone morphogenic protein prior to pursuing FDA approval for use in spinal fusion.